-
SCHOTT AG appoints Pawan Kumar Shukla as MD for Indian pharma glass business
expresspharma
September 14, 2020
SCHOTT AG has announced Pawan Kumar Shukla as the new MD for SCHOTT Glass India. He will take charge at SCHOTT’s tubing plant in Jambusar, Gujarat.
-
IRBM Signs Agreement with MD Anderson Cancer Center
contractpharma
September 12, 2019
IRBM has signed a service and development agreement with The University of Texas MD Anderson Cancer Center.
-
Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
worldpharmanews
August 14, 2019
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for various types of cancers,
-
Boehringer Ingelheim, MD Anderson Form Virtual Cancer R&D Center
contractpharma
August 13, 2019
New potential gastrointestinal and lung cancer therapies from Boehringer’s pipeline will be combined with MD’s drug development capabilities.
-
Precigen Opens Cell Therapy Mfg. Facility in MD
contractpharma
April 28, 2019
Precigen, Inc., a wholly-owned subsidiary of Intrexon Corp. and a clinical stage biopharmaceutical company specializing in the development of gene and cellular therapies has opened its new manufacturing facility in Germantown, MD.
-
MD Anderson Cancer Centre, 4D pharma collaborate to evaluate live biotherapeutics in solid tumors
biospectrumasia
January 07, 2019
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate 4D’s live biotherapeutic oncology pipeline across a range of cancer settings.
-
JCI appoints John Yoon as MD of Asia-Pacific Region
biospectrumasia
June 14, 2018
Yoon joined JCI in January 2017. With more than 13 years of experience in health care and finance, he brings a wealth of knowledge in leading large-scale projects, as well as financial and operational consulting for health care systems and cross-border bu
-
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership
firstwordpharma
May 30, 2018
Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center today announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by research
-
IPGA felicitates Dilip Sanghvi, MD, Sun Pharma
financialexpress
May 21, 2018
The Local Organising Committee of the 70th Indian Pharmaceutical Congress (IPC) recently felicitated Dilip Sanghvi, Managing Director, Sun Pharma in New Delhi.
-
Tamoxifen and raloxifene slow down the progression of muscular dystrophy
europeanpharmaceuticalreview
March 22, 2018
Long-term treatment with selective estrogen receptor modulators improves muscle, respiratory, and skeletal function without weakening bone in new mouse studies…